Safe and Successful Medication Management Strategies and All Provider Communication for Patient Receiving an LAAO Device - 2022 Quality Summit presentation (Non-CE)-Session

Video Transcription

Video Summary

The video is a presentation by Dr. Thomas Dooland, a cardiac electrophysiologist, who discusses left atrial appendage (LAA) occlusion and the importance of post-implant medication regimens. LAA occlusion is a treatment strategy for patients with atrial fibrillation (AF) to reduce their risk of stroke. Dr. Dooland explains that during AF, the atria beat rapidly, leading to stagnant blood flow in the LAA, which can form clots that may cause a stroke if they travel to the brain. LAA occlusion devices, such as the Watchman and Amulet, are implanted to seal off the LAA and prevent clot formation. <br /><br />Dr. Dooland emphasizes the need for medication adherence after LAA occlusion to prevent device-related thrombus. He discusses the various medication regimens used, including anticoagulants and antiplatelet agents, and their importance in facilitating device healing and preventing stroke. However, the optimal duration and combination of medications remain uncertain. Communication challenges arise due to multiple regimens used, specialized LAA occlusion centers, increased bleeding risk, and involvement of various healthcare providers. Dr. Dooland suggests strategies to enhance medication adherence, such as direct communication with patients and referring physicians, providing patients with a letter explaining the medication plan, and emphasizing the importance of contacting the implanting team in case of bleeding or emergency situations. Overall, his goal is to improve patient outcomes and minimize complications after LAA occlusion.

Keywords

Dr. Thomas Dooland

cardiac electrophysiologist

left atrial appendage occlusion

post-implant medication regimens

atrial fibrillation

stroke prevention

LAA occlusion devices

medication adherence